SUCLA2 activators encompass a range of chemicals that facilitate the activation of the SUCLA2 protein, which is a subunit of the succinate-CoA ligase enzyme complex involved in the citric acid cycle, also known as the tricarboxylic acid (TCA) cycle or Krebs cycle. This protein plays a critical role in the conversion of succinyl-CoA to succinate, with the concurrent formation of ADP or GDP from ATP or GTP, respectively, thereby contributing to the cellular energy metabolism.
Direct activators of SUCLA2 interact with the protein in a manner that enhances its enzymatic activity. This could involve binding to the active site of the enzyme in such a way that it increases the affinity of SUCLA2 for its substrates, succinyl-CoA and nucleoside diphosphates (ADP/GDP). They might also induce a conformational change in the SUCLA2 protein or its complex that promotes a more efficient catalysis of the reaction it mediates. Furthermore, these activators could prevent inhibitory molecules from interacting with SUCLA2, thereby increasing its overall activity. On the other hand, indirect activators of SUCLA2 might work by modulating the levels of substrates available to the enzyme or by influencing the expression and stability of the SUCLA2 protein. They can enhance the synthesis of succinyl-CoA and ADP/GDP, making them more readily available to the SUCLA2 complex. Alternatively, these activators might also act by modifying the mitochondrial environment to favor the activity of the SUCLA2 complex or by influencing post-translational modifications that enhance the protein's stability and function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dichloroacetic acid | 79-43-6 | sc-214877 sc-214877A | 25 g 100 g | $60.00 $125.00 | 5 | |
Dichloroacetate activates pyruvate dehydrogenase, enhancing the conversion of pyruvate to acetyl-CoA, which can lead to increased TCA cycle flux and potentially influence SUCLA2. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR activates AMPK, which can enhance catabolic processes like the TCA cycle, potentially influencing SUCLA2. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $286.00 $806.00 $1510.00 | 1 | |
Metformin activates AMPK, leading to an increased rate of catabolic processes, including the TCA cycle where SUCLA2 operates. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $75.00 $163.00 $622.00 $4906.00 $32140.00 | 43 | |
Sodium phenylbutyrate is a histone deacetylase inhibitor that can alter gene expression, potentially influencing SUCLA2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can alter gene expression, potentially influencing SUCLA2. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor that can alter gene expression, potentially influencing SUCLA2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, leading to AMPK activation which can enhance catabolic processes like the TCA cycle, potentially influencing SUCLA2. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinases, which can disrupt various signaling pathways and potentially influence SUCLA2 indirectly by altering cellular metabolism. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, altering gene expression and potentially influencing SUCLA2. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid is a histone deacetylase inhibitor that can alter gene expression, potentially influencing SUCLA2. | ||||||